Congress Interrogates PBM Chiefs – The Hill

TL/DR –

Pharmacy Benefit Manager (PBM) executives are set to face scrutiny from the House over healthcare costs. The Federal Trade Commission (FTC) is reportedly preparing to sue PBMs, including CVS, over how they negotiate drug prices. This is part of a wider examination of the role of PBMs in the pharmaceutical industry and their impact on healthcare costs.

PBM Executives under Investigation

Pharmacy Benefit Manager (PBM) executives are being investigated by the House, according to a report by The Hill. This investigation puts PBM executives in the hot seat, as reported by Axios.

FTC’s Lawsuit against CVS

In related news, the Federal Trade Commission (FTC) is about to file a lawsuit against CVS regarding the company’s negotiation of drug prices. The Boston Globe elaborated on what consumers need to know about this upcoming lawsuit in their article.

US House Panel Hearing on Healthcare Costs

In a bid to address escalating healthcare costs, the US House panel will hold a hearing with pharmacy benefit managers. This information was provided by Reuters.

FTC’s Moves Against PBM’s

According to JD Supra, media reports suggest that the FTC is set to sue pharmacy benefit managers. For more information, read the full report here.

—
Read More Health & Wellness News ; US News